Celesztina Nagy-Domonkos

Celesztina Nagy-Domonkos has a wealth of work experience. Celesztina began their career in 2008 as a Chemistry Lab Assistant at EGIS Pharmaceuticals PLC. Celesztina then moved on to the Hungarian Academy of Sciences, Research Centre for Natural Sciences in 2010, where they held the roles of PhD student in Chemistry and Research Assistant. In 2015, they became a Senior Scientist at Nova Biomedical. Celesztina then moved to Charles River Laboratories in 2018, where they served as a Principal Scientist. Finally, in 2019, they joined Pandion Therapeutics as a Senior Scientist and is currently a Senior Principal Scientist at Werewolf Therapeutics since 2021.

Celesztina Nagy-Domonkos received their Doctor of Philosophy (Ph.D.) in Chemistry from Eötvös Loránd University in 2016. Prior to that, they obtained their Master of Science (MSc) in Chemistry with a Pharmaceutical chemistry specialization from the same university in 2010.